Skip to main content

Table 1 List of identified peptides

From: The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway

UniProt name Protein name Sequence From–to
Higher signal intensities in LS and VS
 1433B_MOUSE 14-3-3 protein beta/alpha L.WTSENQGDEGDAGEGEN.- 230–246
 1433Z_MOUSE 14-3-3 protein zeta/delta L.WTSDTQGDEAEAGEGGEN.- 228–245
 RLA2_MOUSE 60S acidic ribosomal protein P2 -.MRYVASYLLAALGGN.S 1–15
 ATPB_MOUSE ATP synthase subunit beta, mitochondrial A.AQASAAPKAGTATGRIVA.V 48–65
 ATPB_MOUSE ATP synthase subunit beta, mitochondrial Y.AAQASAAPKAGTATGRIVA.V 47–65
 ATP5H_MOUSE ATP synthase subunit d, mitochondrial M.AGRKLALKTIDWVSF.V + Acetyl (N-term) 2–16
 KCRB_MOUSE Creatine kinase B-type L.IEMEQRLEQGQAIDDLMPAQK.- 361–381
 IF4H_MOUSE Eukaryotic translation initiation factor 4H N.SAIFGGARPREEVVQKEQE.- 230–248
 IF4H_MOUSE Eukaryotic translation initiation factor 4H M.ADFDTYDDRAYSS.F + acetyl (N-term) 2–14
 G3P_MOUSE Glyceraldehyde-3-phosphate dehydrogenase N.RVVDLMAYMASKE.- 321–333
 G3P_MOUSE Glyceraldehyde-3-phosphate dehydrogenase M.FQYDSTHGKFNGTVKAEN.G 45–62
 G3P_MOUSE Glyceraldehyde-3-phosphate dehydrogenase L.ISWYDNEYGYSNRVVDLMAYMASKE.- 309–333
 G3P_MOUSE Glyceraldehyde-3-phosphate dehydrogenase M.VKVGVNGFGRIGRLVTRA.A 2–19
 G3P_MOUSE Glyceraldehyde-3-phosphate dehydrogenase M.VKVGVNGFGRIGRLVT.R 2–17
 GBB2_MOUSE Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 M.SELEQLRQEAEQLRN.Q + acetyl (N-term) 2–16
 ESTD_MOUSE S-Formylglutathione hydrolase T.FIADHIRHHAKYLNA.- 268–282
 TPIS_MOUSE Triosephosphate isomerase M.APTRKFFVGGN.W 52–62
 G6PI_MOUSE Glucose-6-phosphate isomerase M.AALTRNPQFQKLLEWHRAN.S + acetyl (N-term) 2–20
 G6PI_MOUSE Glucose-6-phosphate isomerase N.GLISFIKQQRDTKLE.- 544–558
Higher signal intensities in VS, LC, VC
 DPYL2_MOUSE Dihydropyrimidinase-related protein 2 S.SAKTSPAKQQAPPVRNLH.Q 518–535
 DPYL2_MOUSE Dihydropyrimidinase-related protein 2 V.APPGGRANITS.L 560–570
 DPYL2_MOUSE Dihydropyrimidinase-related protein 2 V.APPGGRANITSLG.- 560–572
 EAA2_MOUSE Excitatory amino acid transporter 2 M.ASTEGANNMPKQVEVRMHDSHLS.S + acetyl (N-term) 2–24
 EAA2_MOUSE Excitatory amino acid transporter 2 M.ASTEGANNMPKQVEVRMHDSH.L + acetyl (N-term) 2–22
 MBP_MOUSE Myelin basic protein V.TPRTPPPSQGKG.R 93–104
 MBP_MOUSE Myelin basic protein R.TPPPSQGKGRGLS.L 96–108
 MBP_MOUSE Myelin basic protein I.VTPRTPPPSQGKG.R 92–104
 MBP_MOUSE Myelin basic protein N.IVTPRTPPPSQGKGRGLSLS.R 91–110
 MBP_MOUSE Myelin basic protein N.IVTPRTPPPSQGKG.R 91–104
 MBP_MOUSE Myelin basic protein R.TPPPSQGKGRGLSLS.R 96–110
 MBP_MOUSE Myelin basic protein V.TPRTPPPSQGKGRGLSLS.R 93–110
 MBP_MOUSE Myelin basic protein K.RPSQRSKYLATA.S 6–17
 MBP_MOUSE Myelin basic protein Q.KRPSQRSKYLATA.S 5–17
 MBP_MOUSE Myelin basic protein M.ASQKRPSQRSKYLAT.A + acetyl (N-term) 2–16
 MBP_MOUSE Myelin basic protein M.ASQKRPSQRSKYLATA.S + acetyl (N-term) 2–17
 MBP_MOUSE Myelin basic protein M.ASQKRPSQRSKYLATAS.T + acetyl (N-term) 2–18
 MBP_MOUSE Myelin basic protein M.ASQKRPSQRSKYLATAST.M + acetyl (N-term) 2–19
 MBP_MOUSE Myelin basic protein M.ASQKRPSQRSKYLATASTMD.H + acetyl (N-term); oxidation (M) 2–21
 MBP_MOUSE Myelin basic protein M.ASQKRPSQRSKYLATASTMDH.A + acetyl (N-term); oxidation (M) 2–22
 MBP_MOUSE Myelin basic protein M.ASQKRPSQRSKYLATASTMDHA.R + acetyl (N-term) 2–23
 MAG_MOUSE Myelin-associated glycoprotein G.KRPTKDSYTLTEELAEY.A 604–620
 NEUG_MOUSE Neurogranin K.GPGPGGPGGAGGARG.G 55–69
 NEUG_MOUSE Neurogranin P.GGPGGAGGARGGAGGGPSGD.- 59–78
 NEUG_MOUSE Neurogranin R.KGPGPGGPGGAGGARGGAGGGP.S 54–75
 NEUG_MOUSE Neurogranin K.GPGPGGPGGAGGARGGAGGGPSGD.- 55–78
 NEUG_MOUSE Neurogranin R.KGPGPGGPGGAGGARGGAGGGPSGD.- 54–78
 NEUG_MOUSE Neurogranin G.RKGPGPGGPGGAGGARGGAGGGPSGD.- 53–78
 SNG3_MOUSE Synaptogyrin-3 A.YPGYPVGSGVEGTETY.Q 193–208
  1. The table depicts the UniProt name, the precursor protein name, the amino acid sequence and the amino acid range of identified peptides. The dot within the sequence denotes the cleavage site. The top part list peptides found to possess significant higher signal intensities in stroke samples and the bottom part peptides possessing significant lower signal intensities in linagliptin-stroke samples